Actively Recruiting
SLEEP-COPE Telehealth Sleep Treatment Using Cognitive Behavioral Therapy for Children Ages 8 to 12 with Oppositional Defiant Disorder and Insomnia
Led by University of South Florida · Updated on 2025-03-28
25
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Children diagnosed with Oppositional Defiant Disorder ODD often face problems such as insomnia, mood difficulties, and challenges with compliance. Researchers are evaluating a telehealth-delivered cognitive behavioral treatment for insomnia CBT-I called SLEEP-COPE, designed specifically for children with ODD and their parents. This trial aims to develop and test this brief dyadic therapy to improve sleep and related issues, especially in areas with limited mental healthcare access. The study uses the SLEEP-COPE program, which combines standard CBT-I methods like sleep hygiene, stimulus control, sleep restriction, and cognitive therapy with strategies tailored to children with ODD and their parents. The treatment involves active participation from both children and parents, with parents helping implement behavioral strategies. The intervention is delivered remotely via telehealth to reduce the burden of in-person visits. Participants will complete daily sleep diaries for both children and parents over 14-day periods at baseline, 6 weeks, and 10 weeks. They will also wear actigraphy devices continuously during these 2-week assessment periods to monitor sleep patterns. Additional assessments include child salivary and hair cortisol, anxiety and depression scales, parenting questionnaires, stress scales, and behavioral checklists at the same time points. The study monitors multiple outcomes related to sleep, mood, behavior, and parenting over approximately 10 weeks.
CONDITIONS
Brief Title
SLEEP-COPE: Sleep Intervention for Oppositional Children
Research Team
M
Melanie A Stearns, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here